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The wound healing process initiates after injury to a tissue and involves a series
of orchestrated events to minimize the invasion of foreign matters such as bacteria
and efficiently regenerate the damaged tissue. A variety of cells must be recruited
to the tissue during wound healing. However, this process is severely disrupted in
patients suffering from chronic illness, including diabetes, leading to impaired healing
or non-healing wounds. Current avenues of treatment include negative-pressure therapy,
wound debridement, growth factor replacement, and cell-based therapies. Among these
therapies, mesenchymal stem cells (MSCs) delivery to the wound holds a very high
promise due to the innate abilities of MSCs that include immunogenicity, plasticity, and
self-renewal. Bone marrow derived MSCs have been shown to promote more rapid
wound healing by increased cytokine production in diabetic mice. However, the lack
of understanding of the mechanical and chemical interaction of the transplanted MSCs
with the factors present in the regenerative niches limits their efficacy in the wound
bed. In this study, we sought to understand how the changes in MSC biochemical and
biophysical properties can affect their function in vitro and in vivo. We demonstrate that
pretreatment of MSCs with the mechano-stimulatory soluble factor transforming growth
factor (TGF-β1), which is highly expressed in injury sites, improves wound closure in a
syngeneic murine wound model. This improved wound closure correlated with increased
invasion into the wound bed. In vitro studies demonstrated that TGF-β1 pretreatment
expedited wound closure by increasing adhesion, traction force, and migration even after
removal of the stimulus. Furthermore, this response was mediated by the cytoskeletal
protein focal adhesion kinase. Taken together, this study suggests that defined chemical
stimuli can benefit site specific adaptability of MSCs to improve their function and
therapeutic usefulness.
Keywords: wound healing, mesenchymal stem cells (MSCs), transforming growth factor—β1 (TGF-β1), adhesion,
migration, focal adhesion kinase (FAK)
INTRODUCTION
Skin is the outermost tissue that acts as a barrier against foreign matter incursion into the body.
Injury to skin initiates the wound healing process, which includes three distinct but temporally
overlapping series of events namely, inflammation, proliferation, and remodeling (Diegelmann and
Evans, 2004; Guo and Dipietro, 2010; Takeo et al., 2015). During inflammation, platelets secrete
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a host of soluble factors to attract neutrophils and macrophages,
and these cells subsequently remove the contaminants from
the wound bed and protect wound site from further infection.
Once the inflammation process subsides, the healing process
enters the proliferation stage which is characterized by fibroblast
migration, matrix deposition and granulation tissue formation,
angiogenesis, and re-epithelialization. Finally, the healing process
moves to the remodeling phase which requires simultaneous
deposition and degradation of extracellular matrix including
collagen isoforms, to form scar tissue and rebuild the native
architecture of the skin. However, the progress of the healing
events are severely disrupted in elderly patients and patients
suffering from chronic illness, including diabetes, ischemia, or
hypertension, leading to non-healing chronic wounds (Gosain
and DiPietro, 2004; Brem and Tomic-Canic, 2007; Guo and
Dipietro, 2010). Chronic wounds are caught in a state of constant
inflammation which disrupts the initiation of later phases and
it is characterized by impaired production of cytokines and
growth factors and reduced angiogenesis (Werner and Grose,
2003; Barrientos et al., 2008; Lazaro et al., 2016). Nearly 1%
of the population in developed countries suffers from chronic
wounds (Simka and Majewski, 2003; Gottrup, 2004). In United
States alone, chronic wounds affect 6.5 million people and
incur an estimated annual cost of USD 25 billion (Sen et al.,
2009). Conventional treatment of the chronic wounds includes
surgical debridement, biological dressing, pressure oﬄoading,
and topical growth factors. However, these methods provide very
limited results in most cases (up to 50%) and new therapies are
required to overcome the current challenges of chronic wound
management (Greer et al., 2013; Dreifke et al., 2015; Rowan et al.,
2015; Sessions et al., 2017). Recent studies have indicated that
cell based therapies can provide a suitable alternative treatment
method for multiple pathological conditions including, wound
healing (Chen et al., 2012; Rodriguez-Menocal et al., 2015;
Duscher et al., 2016).
Mesenchymal stem cells (MSCs) are multipotent cells that
actively participate in tissue repair and regeneration in vivo.
MSCs can be isolated and expanded with relative ease and
their immunogenicity sets them as the ideal candidate for both
autologous and allogeneic transplantation in wound healing
(Bobis et al., 2006; Murphy et al., 2013). Both preclinical studies
with animal models and clinical studies have demonstrated
effectiveness of MSCs in accelerating chronic wound healing
(Wu et al., 2007a; Jackson et al., 2012; Isakson et al., 2015;
Kim et al., 2015; Kirby et al., 2015). MSCs added (topical
delivery) or recruited (systemic delivery) to the wound bed are
believed to participate in healing process by one of the following
mechanisms: (1) releasing paracrine factors e.g., cytokines,
and (2) differentiating into cell phenotypes e.g., keratinocytes,
required for regeneration (Wu et al., 2007b; Chen et al., 2008;
Sasaki et al., 2008; Kuo et al., 2016). Despite the recent progress
in evaluatingMSC based therapies for wound healing, the distinct
interaction of MSCs with the mechanical and chemical cues
present in wound bed is not fully understood and this currently
limits the extensive use of MSCs in clinical capacity. Previous
studies have reported that wound stiffness increases dramatically
during the healing process and modifies the function of
underlying cells, e.g., fibroblasts, in both normal and pathological
conditions (Goffin et al., 2006; López et al., 2010; Liu et al., 2010a;
Chao et al., 2013; Klingberg et al., 2013; Darby et al., 2014).
In addition to the biochemical signals present in the wound
milieu, such mechanical cues e.g., matrix elasticity, can also affect
the MSC function profoundly (Engler et al., 2006; Kilian et al.,
2010; Tse and Engler, 2011; MacQueen et al., 2013). Studies with
polyacrylamide (PA) substrate of varying elasticity have reported
stiffness dependent migration of cells in the context of wound
healing (Ng et al., 2012; Raab and Discher, 2016). It is now
widely accepted that substrate stiffness can influence a myriad
of fundamental properties and functions of diverse cell types
includingMSCs (Discher et al., 2005, 2009; Eyckmans et al., 2011;
Janmey and Miller, 2011; Charras and Sahai, 2014; Humphrey
et al., 2014). In this study, we sought to understand the
effect of inducing phenotypical changes (including mechanical
properties) in MSCs on its function in wound bed and wound
healing rate. We have previously characterized the mechanical
and chemical response of MSCs in vitro to soluble factors
present in regenerative niches (Ghosh et al., 2014). Transforming
growth factor β1 (TGF-β1), a pleiotropic protein belonging to
the TGF-β superfamily, regulates a myriad of cell functions
including, proliferation, differentiation, adhesion, migration, and
apoptosis (Massagué, 1998; Heldin et al., 2009; Watabe and
Miyazono, 2009). TGF-β1 plays a significant role throughout the
phases of wound healing (Gilbert et al., 2016). Our studies with
soluble factor TGF-β1 provided enhanced mechanical response
with cytoskeletal remodeling and stiffening of MSCs (Ghosh
et al., 2014). TGF-β1 treated MSCs also provided molecular
response to indicate adhesive strengthening, ECM remodeling
and differentiation (Ghosh et al., 2014). This study sought to
understand if TGF-β1 pretreatment induced modification in
MSC phenotype can alter their in vitro and in vivo behavior. We
hypothesized that migrating MSCs that disseminated throughout
the wound bed would contribute to the formation of granulation
tissue, which would constrict the wound for more rapid wound
closure. Improved MSC migration could also improve the spatial
and temporal activity of growth factors and cytokines since
they were secreted from MSCs that disseminated throughout
the wound tissue. Injection of TGF-β1 pretreated MSCs at the
periphery of skin wounds resulted in increased wound closure
rates compared to control MSCs. TGF-β1 pretreated MSCs
also demonstrated greater distribution toward the center of the
wound compared to control cells. The persistent characteristics
of TGF-β1 pretreated cells can be beneficial for treatment
of chronic wounds, where cell functions are arrested due to
rapid degradation of soluble factors. To better understand the
effects of TGF-β1 pretreatment, we performed multiple in vitro
functional analyses of MSCs up to 24 h after removal of initial
stimulus. TGF-β1 treatment resulted in dramatically elongated
morphology and this phenotype was maintained even after 24
h of removal of the stimulus. Similarly, TGF-β1 pretreated cells
sustained the enhanced surface expression of αv, β1, and β3
integrins as determined by flow cytometry and subsequently
displayed higher adhesive strength compared to control cells.
To better understand the initial cell attachment process, we
used 34 kPa PA substrates that closely match the stiffness of
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the wound bed (Goffin et al., 2006; Discher et al., 2009). TGF-
β1 pretreated cells adhered and spread more efficiently on
the PA substrates and generated significantly higher traction
forces. TGF-β1 pretreatment also enhanced the soluble factor-
mediated migration of MSCs. Additionally, using small molecule
inhibitors to disrupt certain well known pathways associated
with cell functions, we found that focal adhesion kinase (FAK)
signaling is key for enhanced performance of TGF-β1 pretreated
cells.
MATERIALS AND METHODS
Materials
IMDM, DMEM, L-glutamine, penicillin-streptomycin, and
trypsin were purchased from Mediatech and fetal bovine serum
(FBS) was purchased from Atlanta Biologicals. Recombinant
human TGF-β1, PDGF and IGF-I proteins and flow cytometry
antibodies were purchased from Biolegend. Recombinant
proteins were solubilized in phosphate buffered solution (PBS)
containing 1% bovine serum albumin (BSA) and stored in−80◦C
as per manufacturer’s recommendation. All other reagents were
purchased from VWR unless otherwise specified.
MSC Isolation and Culture
Murine MSCs were isolated from the bone marrow of 6–10
weeks old adult male Balb/C mice (Charles River Laboratories,
Wilmington, MA) and cultured in normal growth media (IMDM
media supplemented with 20% FBS, 2 mM L-glutamine, 100
U/ml penicillin, and 100 U/ml streptomycin). Purified MSCs
between passages 2–6 were used for all studies after thorough
characterization (Supplementary Figure 1). All animal studies
were approved by the Institutional Animal Care and Use
Committee at Georgia Institute of Technology (PHS Assurance
Number 3822-01).
Soluble Factor Pretreatment
Soluble factor dilutions were created from aliquots in serum-free
DMEM or IMDM immediately before use. Based on literature
review and our previous studies, TGF-β1 concentration of 5
ng/ml was used for treatment of MSCs (Ghosh et al., 2014).
Initially, MSCs were pretreated with serum-free control media
(CM), and 5 ng/ml TGF-β1 (diluted in serum free media) for
24 h. Afterwards, the stimulations were removed and both
control and pretreated cells were moved to serum free or
specific differentiation induction media to determine the effects
of pretreatment on MSC functions. To avoid confusion, the
removal of growth factor stimulus was assigned as t0; whereas the
time points for each experiment were indicated as t0 + t h. For
example, centrifugation based adhesion assays described in this
section were carried out at t0 + 24 h.
Wound Preparation and Mesenchymal
Stem Cell Transplantation
An in vivo punch biopsy wound healing model was used to
determine the effects of MSC pretreatment on wound healing
(McGrail et al., 2013). To account for mouse to mouse variation,
all mice had one wound injected with control media pretreated
MSCs and one TGF-β1 pretreated MSCs (Supplementary Figure
2). Briefly, hair was removed from the dorsal surface of
anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine or
isoflurane gas) 12-week old male Balb/C mice by shaving and
Nair hair removal. One 5 mm full-thickness skin wound was
made on each side of the dorsal midline using a punch biopsy
tool (to trace the wound perimeter) and iris scissors (to remove
the tissue). Concurrently, pretreated MSCs were detached and
labeled with the lipophilic tracer dye DiD (Invitrogen). Mouse
mesenchymal stem cells (5.0× 105) suspended in a small volume
of PBS solution (∼100 µl) were injected (30-gauge needle)
intradermally at the wound periphery of anesthetized mice. All
animal studies were approved by the Institutional Animal Care
and Use Committee at Georgia Institute of Technology (PHS
Assurance Number 3822-01).
Wound Healing Analysis
After seven days, animals were sacrificed and wound tissues were
collected to image the fluorescently labeledMSCs.Wound tissues
were stained with DAPI to highlight the nuclei and were then
mounted on slide for imaging. The wound bed was imaged using
Nikon Eclipse Ti inverted fluorescence microscope and an image
of the entire wound area was created by stitching together all the
individual images in Nikon Elements. The images were further
analyzed by quantifying the fluorescence intensity across the
distance between the centroid of the injection sites as previously
discussed (McGrail et al., 2013).
Morphological Analysis
Control and pretreated MSCs were cultured for 24 h after the
removal of stimulus (t0 + 24 h) and were stained with crystal
violet. Cells were then imaged with stereoscope microscope and
Motic camera. Cell borders were traced manually and cell shape
factors, defined as 4∗pi∗Area/ (Perimeter) 2, were determined
using Image J.
Centrifugal Force Based Adhesion Assay
Briefly, control and pretreated MSCs were trypsinized and
labeled with Calcein AM. Then the cells were seeded in an
uncoated 96-well plate in serum-free media. At 24 h after
stimulus was removed (t0 + 24 h), an initial fluorescence reading
was recorded. Cells were detached by centrifuging inverted plates
at 500× g for 3min before recording a final fluorescence reading.
The adherent fraction was determined by normalizing the final
florescence values with the initial pre-spin values (McGrail et al.,
2013).
Flow Cytometry
Briefly, both treated and untreated cells were cultured for 24
h after the removal of stimulus (t0 + 24 h), detached from
surface, centrifuged, and suspended in 100 µl cold FACS buffer
(2% FBS, 1mM EDTA in PBS) with one of the following anti-
mouse antibodies (dilutions in parentheses): FITC-CD29 (1:100),
PE-CD61 (1:100), PE-CD51 (1:20), AF-647-MVCAM1/CD106
(1:200). Following the incubation, MSCs were washed and fixed
in 2% paraformaldehyde. Samples were run on a BD LSR-II flow
cytometer to capture at least n= 50,000 events per sample.
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Fabrication of Polyacrylamide (PA)
Substrates
PA hydrogels were used as an elastic 2D cell culture platforms due
to extensive characterization of their mechanical properties that
can be easily tuned by controlling crosslinker concentration(Tse
and Engler, 2010; Caliari and Burdick, 2016; Polacheck and
Chen, 2016). PA substrates were synthesized based on the
protocol described before (Tse and Engler, 2010). Briefly, glass
coverslips were activated using 3-aminopropyltrimethoxysilane
and a mixture of the acrylamide and bis-acrylamide solution
(10% acrylamide to 0.3% bis-acrylamide) was polymerized on
the activated glass coverslips (Young’ modulus (E) ∼34 kPa).
Substrates were coated with type I collagen solution (0.2 mg/ml)
before cell culture.
Adhesion Assay
Control and pretreated MSCs were trypsinized and labeled
with a transmembrane fluorescent viability marker, Calcein AM
(Anaspec), in HBSS containing divalent ions Ca++ and Mg++.
Then the cells could adhere for 3 h after stimulus was removed
(t0 + 3 h) in HBSS before taking an initial florescence reading in
a DTX-800 Multimode Detector plate reader. A final reading was
taken after removing non-adherent cells by washing with HBSS
to determine the adherent fraction.
Traction Force Microscopy
Control and pretreated MSCs were seeded on collagen-coated
PA substrates embedded with 200-nm fluorescent microbeads,
for 24 h. Particle displacements were determined by comparison
of the embedded bead positions before and after the cells were
detached from the gels and used to determine traction forces with
a Fourier-transform traction force cytometry in a custom-written
MATLAB routine as previously described (Sabass et al., 2008).
Inhibitor Studies
PF573228, Ly294002, and SIS3 were used to inhibit FAK,
PI3K, and SMAD3 mediated signaling, respectively. Range
of concentrations for all the inhibitors were determined
from literature reviews and MSCs were treated with 10 µM
concentration (Jeon et al., 2008; Qureshi et al., 2008; Gharibi
et al., 2012; Zhang et al., 2015, 2016). For adhesion studies cells
control and pretreated cells were detached and suspended in
inhibitor supplemented serum free media for 2 h before seeding
on a 96-well plate. Then the cells could adhere for 3 h before
taking an initial florescence reading. A final reading was taken
after removing non-adherent cells by washing with HBSS to
determine the adherent fraction. For both motility and scratch
assay cells were treated with inhibitors for 2 h before adding the
migration stimulating factor PDGF (15 ng/ml).
Motility Assay
Cells were treated with control and TGF-β1 supplemented media
for 24 h in 10 cm dishes. Both control and pretreated MSCs were
trypsinized and seeded on collagen coated 48-well plate at a sub-
confluent density for 12 h. Wells were then washed to remove
detached cells before staining with Hoechst 33,342 for 30 min.
Cells were then treated with soluble factors before placing them
on Nikon Eclipse Ti inverted epifluorescent microscope, which
was maintained at 37◦C and 5% carbon dioxide throughout
the experiment using an In vivo Scientific environmental cell
chamber. Images of the nucleus were taken using DAPI filter
(excitation 358 nm and emission 461 nm) at multiple points at
12 min- interval for 6–8 h at 10x magnification. The locations of
cell nuclei, segmented from fluorescent images, were tracked in
MATLAB to define cell traces. The cell migration coefficients and
directional velocities were determined by fitting the traces to the
persistent randomwalk model (Dickinson and Tranquillo, 1993).
Briefly, mean square displacements were calculated (MSD =
d2 (τ )) from the two-dimensional tracking data and was used
for fitting the following equation: (where, d = displacement, t =
time, P= persistence time, and µ =migration coefficient).
〈d2 (τ)〉 = 4µ
{
t − P
[
1− e−t/P
]}
Scratch Assay
Cells were cultured as a confluent monolayer on collagen coated
48-well plate and a gap was created by removing cells with a
pipette tip. Wells were then washed to remove detached cells
before staining with Calcein AM. Cells were then treated with
soluble factors before placing them on Nikon Eclipse Ti inverted
epifluorescent microscope, which was maintained at 37◦C and
5% carbon dioxide throughout the experiment using an In vivo
Scientific environmental cell chamber. FITC green channel (495
nm excitation and 515 nm emission) images were taken at
multiple points at 15-min interval for 12 h at 10x magnification.
Statistics
Each experiment was performed with 3 ormore replicates, and all
values expressed as the mean ± s.e.m. For comparison between
two groups student t-test was used. One way Anova test with
repeated measures was used to determine statistical significance
of experiments involving more than two groups. For comparison
between groups, Tukey’s HSD post-test was used. Significance
was reported as ∗ (for p< 0.05), ∗∗ (for p< 0.005), and ∗∗∗ (for p
< 0.0005).
RESULTS
TGF-β1 Pretreatment of MSCs Enhances
Their Distribution in Wound Bed
MSCs have previously been used to increase the rate of wound
closure in full thickness skin wounds; however, untreated MSCs
used in these studies resulted in a modest change in the rate
of wound healing and long-term engraftment of MSCs was
not clearly established. We used a syngeneic mouse wound
healing model to evaluate the effect of TGF-β1 pretreatment
on dissemination of MSCs in vivo. Fluorescently labeled MSCs
(control and TGF-β1 pretreated) were injected at the periphery of
full thickness wounds in Balb/C mice. At day 0 the ratio of TGF-
β1 to controlMSCs treated wounds for all themice were close to 1
suggesting similar areas; however, after day 5 normalized wound
areas were ∼15% reduced suggesting significant wound closure
rate with TGF-β1 pretreated MSCs compared to untreated cells
(Figures 1A,B, Supplementary Figure 3). By day 7, wounds were
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FIGURE 1 | Transforming growth factor–β1 (TGF-β1) pretreated mesenchymal stem cells (MSCs) migrate and distribute efficiently in the wound bed
and improve wound closure rate in Balb/C mice. (A) Full thickness skin wound on Balb/C mice at day 0 and 5. (B) Open area of TGF-β1 pretreated MSCs injected
wound normalized to its respective control. (C) Thresholded fluorescence images of skin tissue showed enhanced distribution of MSCs toward center of the wound.
(D) Quantification of directed distribution of MSCs toward the center of the wound (n = 3). Values given as mean ± s.e.m.; significance is indicated as *(p < 0.05).
mostly closed (Supplementary Figure 4). However, by analyzing
the labeled MSCs in the wound bed we found that TGF-β1
pretreated cells displayed more efficient distribution toward the
center of the wound (Figures 1C,D).
Sustained Morphological Changes at 24 h
After TGF-β1 Pretreatment
We have previously demonstrated that MSCs undergo dramatic
elongation in response to TGF-β1 treatment (Ghosh et al.,
2014). To examine the persistent effect of TGF-β1 on cell shape,
pretreated MSCs were detached and reseeded on a new surface
(TCP) with serum free media in the absence of stimulus for
24 h (t0 + 24 h). Cells were fixed and stained with crystal
violet to analyze cell morphology using a cell shape factor (CSF)
which varies from 0 for a line to 1 for a perfect circle. TGF-
β1 pretreated cells retained the elongation effect even after 24
h (t0 + 24 h; Figure 2A). Control MSCs retained their spindle
shape leading to CSF close to 0.5. Still the cell shape factor of
TGF-β1 pretreated cells was significantly lower (∼0.3) than its
control counterpart indicating dramatic elongation (p < 0.05;
Figure 2B).
TGF-β1 Pretreatment Enhances Integrin
Expression and Adhesive Strength of MSCs
Next we sought to analyze the sustained effect of pretreatment
on adhesive strength of MSCs using a centrifugation force based
assay at 24 h (t0+ 24 h). TGF-β1 pretreated cells maintained their
higher adhesivity to ECM and exhibited a 4.2-fold increase in
the adherent fraction compared to control (Figure 2C). To better
elucidate the role of cell surface adhesion molecules that control
cell-cell and cell-ECM interaction, we analyzed integrin subunits
αv (CD51), β1 (CD29), β3 (CD61), and vascular cell adhesion
molecule-1 (VCAM-1, CD106) using flow cytometry at this time
point (t0 + 24 h; Figure 2D, Supplementary Figure 5). TGF-β1
pretreated cells displayed significantly upregulated expressions of
the integrins while reducing VCAM-1 expression (Figure 2D).
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FIGURE 2 | Pretreated MSC maintain elongated phenotype. (A) Brightfield images of pretreated MSCs after 24 h stained with crystal violet. TGF-β1 pretreated
MSCs sustained elongated morphology in serum free media for a period of 24 h. (B) Cell shape factor (CSF) was determined by analysis of bright field images with
Image J. CSF was used to characterize the elongation of the cell, with a shape factor of 1 indicating a perfect circle and 0 indicating a straight line. Results are
reported as average ± s.e.m. (n = 2). (C) The centrifuge-based adhesion assay was used to determine the effect of soluble factor pretreatment on the adhesion of
MSCs on uncoated surface. (D) TGF-β1 pretreated MSCs maintain surface adhesion characteristics. Histograms from flow cytometry were analyzed using FACS-DIVA
for mean fluorescence intensity (MFI). Expressions of surface integrins αv (CD51), β1 (CD 29), and β3 (CD61) were increased significantly in TGF-β1 pretreated cells
compared to the control; whereas TGF-β1 pretreatment reduced VCAM1 (CD106) expression significantly compared to the control. (E) Analysis of cell surface
adhesion molecules αv (CD51-PE), β1 (CD29-FITC), and β3 (CD61-PE) integrins, and VCAM-1 (CD106-FITC) using flow cytometry after 24 h of removal of stimulus.
Black and red indicates negative and control cell population; whereas green and blue represent TGF-β1 pretreated cells at immediately (t0) and 24 h (t0 + 24 h) after
the removal of stimulus respectively. TGF-β1 pretreated cells exhibit higher integrin expression and lower VCAM-1 expression at 24 h after removal of the stimulus
compared to control cells. Results are reported as average. (n = 2). Values given as mean ± s.e.m.; significance is indicated as *(p < 0.05), **(p < 0.005).
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Mean fluorescence intensity (MFI) analysis of histograms further
confirmed the trends of integrin upregulation and VCAM-
1 downregulation due to TGF-β1 pretreatment (Figure 2E).
This result correlated with the observed adhesive strengthening
response.
Pretreated MSCs Maintain Adhesive
Phenotype on Wound-Mimetic Substrates
To better understand the difference between pretreated MSCs
and control during the initial stages of attachment in the wound
bed, we used compliant semi-flexible PA substrate with stiffness
(E∼34 kPa) like fibrotic skin wound (Goffin et al., 2006; Discher
et al., 2009). TGF-β1 pretreated MSCs seeded on both collagen
coated glass and PA gel substrates for 3 h (t0 + 3 h) exhibited
>1.7-fold increase in adherent fraction compared to control (p<
0.05; Figure 3A). Furthermore, F-actin staining with Phalloidin
revealed that the TGF-β1 pretreated cells spread more rapidly
and display a well-defined cytoskeletal organization compared
to its untreated counterparts (Figure 3B). We hypothesized that
previously seen change in integrin expression may alter the
traction force exerted by the MSCs on PA substrates. At 24 h
(t0 + 24 h) traction force maps of TGF-β1 pretreated MSCs
displayed very different force distribution compared to control
cells (Figure 3C). Pretreated MSCs displayed very high forces
localized around the edges without any apparent polarization.
Also, the magnitude of overall traction forces exerted by the
TGF-β1 pretreated cells was significantly higher compared to the
control cells (Figure 3D).
TGF-β1 Pretreated MSCs Displayed
Enhanced Cell Motility In vitro
Control and pretreated MSCs were seeded on 48-well plate to
evaluate the effect of soluble factors on cell motility. In presence
of pro-migratory soluble factors PDGF (15 ng/ml) and IGF-
1 (30 ng/ml), the migration coefficients were determined by
tracking the cell nuclei. Both PDGF and IGF-1 enhanced random
FIGURE 3 | TGF-β1 pretreated MSCs display higher adhesivity and traction force after removal of stimulus. (A) TGF-β1 pretreated cells display higher
adhesivity on both glass and gel. (B) Pretreated MSCs (CM vs. TGF-β1) plated on glass and PA gels were washed after 3 h to remove detached cells. (Red-Actin,
Blue- DAPI, Green- Calcein AM). (C) Traction force heat map of CM and TGF-β1 treated MSCs, (D) TGF-β1 pretreated MSCs exerted higher traction force compared
to control after 24 h’ removal of stimulus. Values given as mean ± s.e.m.; significance is indicated as *(p < 0.05).
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cell migration speed of MSCs; however, significant increase in
migration was observed for TGF-β1 pretreated cells compared to
control (Figures 4A,B).
FAK Signaling is Essential for Adhesive
Strengthening and Enhanced Motility
TGF-β1 pretreatment had profound effects on in vitro function
of MSCs including, adhesion and migration. TGF-β1 regulates
cell functions via both canonical and non-canonical pathways. To
further elucidate roles of key signaling pathways in enhanced cell
functions, we blocked following pathways using small molecule
inhibitors: (1) integrin-FAK signaling using PF573228, (2) TGF-
β signaling via SMAD2/3 using SIS3 and (3) growth factor
mediated PI3K signaling with Ly294002. Interestingly, only FAK
inhibitor PF573228 could inhibit TGF-β1 mediated enhanced
migration ofMSCs as the difference inmigratory activity between
TGF-β1 treated cells and control were completely abrogated by
FAK inhibitor (Figures 4C,D). To further evaluate the effects of
the inhibitors on directed migration of MSCs, we used an in vitro
scratch assay that mimics the wound site. Cells migrated toward
FIGURE 4 | TGF-β1 pretreated MSCs displayed enhanced cell motility. (A,B) Cell motility of pretreated MSCs was evaluated in presence of pro-migratory
factors PDGF-BB and IGF-I (present in wound bed). (C,D) Enhanced motility of TGF-β1 pretreated MSCs in presence of PDGF (15 ng/ml) was abrogated by FAK
inhibition (PF573228) but not by PI3K (Ly294002) or SMAD3 (SIS3) inhibition. Values given as mean ± s.e.m.; significance is indicated relative to control unless
otherwise noted, *(p < 0.05).
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an artificially created gap to establish new cell-cell contact under
the influence of PDGF (30 ng/ml). Consistent with the previous
results FAK inhibitor treatment blocked MSC migration toward
the gap (Figures 5A,B). SMAD3 inhibitor, SIS3 was not able
to block TGF-β1 pretreatment dependent directed migration,
implicating a SMAD2/3 independent non-canonical pathway.
Next we analyzed effect of FAK and SMAD3 inhibitors on initial
adhesion on TCP after 3 h and found that both pathways have
significant effect in reducing adhesion (Figure 5C).
DISCUSSION
Wound healing is a very complex process and understanding
the coordinated action of the different types of cells and niche
FIGURE 5 | (A) Scratch assay was used to evaluate directed migration of pretreated MSCs in presence of inhibitors (12 h). (B) TGF-β1 pretreated MSCs displayed
higher directed cells migration toward scratch in a SMAD2/3 independent but FAK dependent manner. (C) Enhanced Adhesive strength of TGF-β1 pretreated MSCs
was both FAK and SMAD3 dependent. Pretreated MSCs (CM vs. TGF-β1) plated on TCP were washed after 3 h to remove detached cells. (D) A simplified diagram
demonstrating the effects TGF-β1 pretreatment on adhesion and migration via integrin-FAK and SMAD pathways. (E) Proposed mechanism of TGF-β1 pretreated
MSCs leading toward improved in vitro functions and enhanced in vivo wound healing. Values given as mean ± s.e.m.; significance is indicated relative to control
unless otherwise noted, *(p < 0.05), ***(p < 0.0005).
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specific soluble and insoluble factors is of utmost importance
for the development of modern wound care. Growth factors
and bioactive materials have been used increasingly in recent
times; however, on their own, there efficacy remains limited
(Greer et al., 2013). Recent studies have highlighted the benefits
of using mesenchymal stem cells for wound healing that holds
high hope for the future of the wound care (Wu et al.,
2007a; Jackson et al., 2012; Isakson et al., 2015; Duscher
et al., 2016). However, characterization of MSCs with niche
specific factors is still in its early stages. In this study, we
have investigated interaction between mesenchymal stem cells
and TGF-β1 a growth factor that plays an important role
both in normal wound healing and in fibrosis(Gilbert et al.,
2016; Meng et al., 2016). The current study was designed to
determine if TGF-β1 induces a persistent alteration in MSC
phenotype, leading to more efficient function in the wound bed
in vivo.
Non-healing wounds are often characterized with loss or
lack of recruitment of motile cells in the wound bed that
are required to close the formed gaps. Even MSCs added
locally to the site often form island like structure with visible
necrosis (Yang et al., 2005). Previous studies with hypoxic
preconditioning and soluble factor (e.g., EGF) pretreatment
have shown to enhance paracrine effects of MSCs as well as
increase in cell migration in vitro and hypothesized that these
outcomes will translate to improved wound healing in vivo (Lee
et al., 2009; Tamama et al., 2010; Kim and Sung, 2012). We
found that TGF-β1 pretreatment contributed to more efficient
propagation of MSCs and increased wound closure rate in
vivo (Figure 1). Further, analysis of the diffusion pattern of
fluorescently labeled MSCs in our study revealed a 2.5-fold
increase in distribution of TGF-β1 pretreated MSCs toward the
center of the wound. This result agrees well with the outcomes
of in vitro migration studies where TGF-β1 pretreated cells
displayed increased directional migration compared to control
cells (Figures 4, 5A,B).
To further understand the function of implanted cells,
we designed a series of in vitro experiments to analyze the
cell–matrix interactions required for adhesion and migration.
Adhesion studies at 3 h (t0 + 3 h) with compliable PA gels (E∼34
kPa) representing the skin tissue stiffness indicated that TGF-β1
pretreatment increased the initial attachment to substrate (Goffin
et al., 2006; Discher et al., 2009). Subsequently, a centrifuge-
based assay at longer time scales (t0 + 24 h) also displayed
similar trend with the measured adherent fraction. Interestingly,
pretreated MSCs displayed more than 4-fold increase in the
adherent cell fraction at 24 h (t0 + 3 h) compared to the 2-
fold increase measured in our washing study after 3 h (t0 + 3
h; Figures 2, 3). These results would account for the adhesive
strengthening due to changes in integrin expression and the
secretion of native ECM proteins by MSCs on uncoated surface
(at t0 + 24 h; Gallant and García, 2007; Michael et al., 2009).
Previous studies have demonstrated enhanced ECM and other
growth factor secretion from cells in response to TGF-β1 and
transcriptional activation of the ECM genes such as collagen
1, fibronectin, and laminins were upregulated in previous
microarray results (Supplementary Table 1; Ghosh et al., 2014).
TGF-β1 pretreatment induced change in adhesion kinetics at
3 h may translate to more successful engraftment efficiency
in vivo, whereas the adhesive strengthening at 24 h could
increase long term survival and integration in wound bed.
Additionally, TGF-β1 pretreated cells were more contractile
on substrates and exerted almost 3-fold higher traction force
(Figures 3C,D).
The phenotypical changes in MSCs due to TGF-
β1 pretreatment that has been reported here are quite
analogous to the changes associated with myofibroblast
differentiation from fibroblast in wound bed with characteristics
including, increase in both αv and β1 integrin expressions,
increase in ECM production, and more motile phenotype
(Thannickal et al., 2003; Lygoe et al., 2004; Häkkinen et al.,
2011). Our analysis confirmed that TGF-β1 pretreated
MSCs maintained an increased surface αv and β1 integrin
expression (Figures 2D,E) which has been correlated with
enhanced migration both in vivo and in vitro and can be
critical for the observed changes in vivo (Liu et al., 2010b;
Veevers-Lowe et al., 2011; Saller et al., 2012; Koivisto
et al., 2014). Myofibroblasts are essential for closure of the
wound gap; however, chronic inflammation may hinder
fibroblast recruitment to wound site and its differentiation into
myofibroblast. TGF-β1 pretreated MSCs that are added locally
can act as an alternative but further studies are required to
characterize the functional difference between these two cell
phenotypes.
All the previous results suggest that TGF-β1 pretreatment
activates an integrin-FAK mediated mechanosensitive pathway
and the sustained response of the cells can be related to
formation of clusters between growth factor-receptors and
integrins that increases and prolongs the signaling in synergy
(Alam et al., 2007; Kim et al., 2011). To examine this
hypothesis, three types of small molecule inhibitors were
used: (1) Ly294002, a PI3K inhibitor was used as a control
to ensure that the enhanced response was not due to cell
proliferation, (2) PF573228 was used to block integrin mediated
FAK activation, and (3) SIS3 was utilized to inhibit TGF-
β1 mediated SMAD3 signaling. Ly294002 didn’t alter the
motility of MSCs indicating that the difference in response
between treated and untreated cells is not an artifact of
growth factor mediated proliferation. FAK activation has been
shown to be essential for myofibroblast differentiation and
wound healing and we here report that inhibiting FAK results
in complete abrogation of adhesion and migration of MSCs
in agreement with previous studies (Thannickal et al., 2003;
Song et al., 2010). Finally, the effect of SIS3 on adhesion
and migration of MSCs were quite interesting. SIS3 could
block the enhanced adhesion of pretreated MSCs; however,
it could not stop the directed migration of cells toward a
scratch. Previous studies have correlated SMAD3 signaling
inhibition with EMT switch, enhanced reepithelization and
wound contraction (Ashcroft et al., 1999). In summary,
the activation of FAK via integrins is essential for both
SMAD3 dependent and independent signal transduction that
are responsible for sustained phenotypical changes associated
with TGF-β1 pretreatment in vitro (Figure 5D). Taken together
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this study suggests that TGF-β1 pretreatment of MSCs can
improve their attachment rate and motility in vivo via activation
of FAK and improves their therapeutic efficacy in wound bed
(Figure 5E).
CONCLUSIONS
The function of ex-vivo expanded MSC based therapeutics
has been shown to be limited after reintroduction in vivo.
This study illustrates that pretreatment of MSCs with TGF-β1
resulted in sustained improvement in migration, and adhesion
even after removal of the stimulus in vitro. Subsequently,
these pretreated cells enhanced the in vivo wound healing
process, which may lead to improved therapeutic efficacy.
Future studies with site specific factors will be used to
guide new strategies for microenvironment specific MSC based
therapy.
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